Novartis reported $45.72B in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
AstraZeneca AZN:LN 26.24B 447M
Canopy Growth Corp WEED:CN C$ 1.99B 514.85M
Corcept Therapeutics CORT:US $ 266.46M 135.44M
Novartis NOVN:VX 45.72B 19.46B
Valeant Pharmaceuticals VRX:CN $ 5607M 283M
Zoetis ZTS:US $ 6930M 248M